{
  "url": "https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020-nisr-2020-349/regulation-15",
  "json_url": "https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020-nisr-2020-349/regulation-15.json",
  "legislation": "nisr/2020/349",
  "legislation_title": "The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020",
  "legislation_url": "https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020-nisr-2020-349",
  "path": "regulation/15",
  "kind": "regulation",
  "number": "15",
  "heading": "Amendment of regulation 250",
  "text": "In regulation 250 (exceptions to regulation 249), after paragraph (4), insert—\n“(4A) A person may, in the course of a business consisting (wholly or partly) of manufacturing medicinal products or of selling products by way of wholesale dealing, sell by way of wholesale dealing a prescription only medicine to any person who by virtue of regulation 247 or 247A may supply or administer that medicine in accordance with a protocol of the types mentioned in those regulations.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/nisr/2020/349/regulation/15",
    "retrieved_at": "2026-10-29T00:40:50.090538+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}